Latest Conference Articles

Understanding the difference between clear and almost clear skin is crucial with the advent of new biologic therapies that make complete clearance attainable.

Psoriasis treatment in the geriatric demographic has long been poorly understood.

Whether it is sitting at the beach, working in the yard or just walking to the grocery store, the risk of developing skin cancer is a risk for everyone. A recent study looked at the impact of the sun particularly for asian and hispanic people.

The number of abuse, addiction, and opioid poisoning diagnoses has decreased since the introduction of reformulated OxyContin, according to a study presented at the American Academy of Pain Medicine's 31st Annual Meeting.

The treatment of vitiligo has come a long way in recent years and there is already work being done to improve treatment in the future.

When treating a patient with vitiligo it can be easy to look at their skin condition and no further. There is work being done to show that more can be done to help the patient not only physically, but mentally as well.

Dermira, Inc. presented clinical data from its successful DRM01 Phase 2a trial in patients with facial acne vulgaris at the American Academy of Dermatology (AAD) Annual Meeting on March 20, 2015 in San Francisco.

In most instances a microscope is enough to make a diagnosis of melanoma, but in some the view under the lens does not provide a clear enough picture. A new test that combines math and science could make the most difficult cases easier to identify.

For anyone who has had or been exposed to someone with chicken pox herpes zoster, or shingles, can be a very real risk. A vaccine for patients over the age of 60 can greatly reduce the likelihood of contracting the disease.

The American Academy of Dermatology is meeting in San Francisco and while there are many noteworthy topics being discussed, melanoma is one of the leading topics of discussion at the event.

Novartis announced results from the CLEAR study demonstrating Cosentyxâ„¢ (secukinumab) improved skin clearance at Week 16 in significantly more moderate-to-severe plaque psoriasis patients compared to Stelara®* (ustekinumab), a widely used biologic.

Preventive angioplasty may be the next big thing. In a study presented at the American College of Cardiology meeting in San Diego, CA, researchers recommended complete revascularization of constricted arteries in patients who had a STEMI heart attack.

Data presented at AAPM 2015 show that moving hydrocodone from Schedule III to Schedule II has led to reduced access to combination hydrocodone medications and other hardships for patients.

Patients with acute coronary syndrome undergoing angioplasty who got the anticoagulant bivalirudin (Angiomax/Medicines Company) had significantly lower rates of bleeding complications and death than controls, according to a Dutch study.

The reporting of PCI results is not a common practice for many reasons, and while some states require it of their doctors, there could be both medical and political barriers standing in the way of it becoming a nationwide program.

With New York and Massachusetts leading the way laws requiring public reporting of PCI results were recently expanded to Washington State as well. A recent study looked at the risks and benefits of other states starting similar programs.

The use of dual anti platelet therapy is popular among cardio patients but questions remain of how long that therapy should continue after a cardiac event.

As technology improves, so does the ability for doctors to better view their patients from a variety of angles as part of their overall care. This is also true in cardiology when treating patients with myocardial diseases.

Countless debates have concluded the practice of pain management to be fragmented compared with other disciplines.

As with any new class of medications there are many questions that will need to be answered by and for healthcare professionals.

If the new class of drugs are as effective as they appear to be in early studies, it could have a drastic affect on how patients with cardiac issues are treated in the future.

One of the hot topics at the American College of Cardiology's annual meeting in San Diego was a new class of drugs being developed that could revolutionize the field of cardiac care.

About two-thirds of surgeons performing mitral valve surgery on patients with atrial fibrillation (AF) do ablation procedures at the same time. There are no official guidelines on when to do both. Trying to provide more information to guide such decisions, a US-Canada team randomized a group of these patients to either valve repair alone, or valve repair with ablation. The dual approach seems better.

Obesity is associated with atrial fibrillation (AF) but the heart condition can be reduced if these patients shed pounds.

The landscape of cardiac care has changed dramatically over the past few years and will continue to well into the future. What it will look like exactly remains to be determined based on a number of factors.

With a new class of drugs on the horizon questions remain about what PCSK9 inhibitors will mean to the future of cardiac care. Doctors are slowly learning the answers to those questions as possible approval draws closer.

Interventional cardiologists would do better to access heart arteries through a patient's arm than groin, a Dutch study found. Though the radial approach is technically more difficult, it is safer with a lower risk of severe bleeding.

As Doctors become more familiar with the new cholesterol guidelines it will be up to them to carry the message to the patients about ways they can improve their overall health.

Physicians may think patients over 80 are too old to benefit from agressive care to treat unstable angina or clogged arteries that caused a heart attack. Think again, a Norwegian researcher said at the American College of Cardiology meeting in San Diego, CA. These patients were 47% more likely to survive and healthier after invasive procedures than a group that got non-invasive care.

It has been many years since guidelines looking at cholesterol control were revised. Now the question is how to keep the new guidelines current even in the future.